Inspira Technologies OXY B.H.N. Ltd. (IINN)
Inspira Technologies OXY B.H.N. Ltd. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Ra'anana, IL. The stock last traded at $1.05, down 0.94% on the session, giving a market capitalisation of $25.3M. On trailing twelve-month figures it carries a trailing P/E of -2.33, a net margin of -4574.4%. Its beta of 2.33 implies it has historically moved more than the broad market.
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers additive manufactured electronics platform that enables 3D architecture for systems operating in dilution cryostats. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
Inspira Technologies OXY B.H.N. Ltd. is most often compared with the following Healthcare names: